Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€106.80
16.08.22
-
16.08.23
-2.62%
16.08.23

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€24.20
16.08.22
-
16.08.23
-4.96%
16.08.23

buy
Republic Services

Start price
Target price
Perf. (%)
€143.20
16.08.22
-
16.08.23
-6.25%
16.08.23

buy
Rbc Bearings Inc.

Start price
Target price
Perf. (%)
€254.00
16.08.22
-
16.08.23
-18.90%
16.08.23

buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€51.50
16.08.22
-
16.08.23
-27.77%
16.08.23

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€104.86
16.08.22
-
16.08.23
-6.73%
16.08.23

buy
Cross Country Healthcare

Start price
Target price
Perf. (%)
€21.40
16.08.22
-
16.08.23
0.93%
16.08.23

buy
Box Inc. A

Start price
Target price
Perf. (%)
€30.48
16.08.22
-
16.08.23
-9.65%
16.08.23

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€94.03
16.08.22
-
16.08.23
-11.99%
16.08.23

buy
American Axle + Mfg Hldgs

Start price
Target price
Perf. (%)
€11.10
16.08.22
-
16.08.23
-40.99%
16.08.23

buy
Altimmune

Start price
Target price
Perf. (%)
€16.61
16.08.22
-
16.08.23
-84.35%
16.08.23

buy
Publity AG

Start price
Target price
Perf. (%)
€29.30
16.08.22
-
16.08.23
-34.13%
16.08.23

buy
Sunopta Inc.

Start price
Target price
Perf. (%)
€11.18
16.08.22
-
16.08.23
-62.36%
16.08.23

buy
Münchener Rückversicherungs-Gesellschaft AG

Start price
Target price
Perf. (%)
€239.10
15.08.22
-
15.08.23
46.68%
15.08.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Top Rating
Very capable Management
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€165.90
15.08.22
€180.00
31.01.24
9.64%
08.05.23

Could be very worthwhile Investment >20% year
buy
Deutsche Konsum REIT AG

Start price
Target price
Perf. (%)
€10.25
14.08.22
€18.00
14.08.24
-2.44%
20.08.22

High dividend yield expected
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.91
13.08.22
€1.00
13.08.23
-12.70%
23.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Revlon Inc.

Start price
Target price
Perf. (%)
€6.50
13.08.22
€1.00
13.08.23
6.31%
04.09.22

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Toughbuilt Industries Inc.

Start price
Target price
Perf. (%)
€5.28
13.08.22
€3.20
13.08.23
-52.42%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.97
13.08.22
€5.00
13.08.23
-6.09%
04.09.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
AMTD IDEA Group ADR

Start price
Target price
Perf. (%)
€4.44
13.08.22
€14.00
13.08.23
0.00%
23.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Redhill Biopharma Ltd ADR

Start price
Target price
Perf. (%)
€1.06
13.08.22
€7.20
13.08.23
-13.55%
23.08.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.97
13.08.22
€14.00
13.08.23
1.02%
22.08.22

Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
micromobility.com Inc.

Start price
Target price
Perf. (%)
€63.00
13.08.22
€100.00
13.08.23
-26.98%
20.08.22

Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Low dividend yield expected
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€48.30
12.08.22
€55.00
12.08.23
-17.99%
13.08.23